Introducing Varenzin™-CA1 (molidustat oral suspension), a groundbreaking advancement in feline healthcare. This innovative medication stands as the FIRST and ONLY FDA conditionally approved option specifically designed for the treatment of non-regenerative anemia in cats with chronic kidney disease (CKD). Varenzin™-CA1 is revolutionizing the standard of care, offering hope and relief to cats grappling with the debilitating effects of this often fatal condition.

Non-regenerative anemia, a common consequence of CKD in felines, has long posed a significant challenge in veterinary medicine. Varenzin™-CA1 addresses this concern with unparalleled efficacy, ushering in a new era of treatment possibilities. With its FDA conditional approval, this medication has proven its potential to make a substantial impact on the lives of cats and their devoted caregivers.

At Five Star Veterinary Center, we are honored to be at the forefront of this veterinary breakthrough, providing Varenzin™-CA1 to our valued clients. We understand the profound impact that feline companions have on our lives, and their well-being is our top priority. If you have any questions or would like more information about Varenzin™-CA1, please do not hesitate to reach out to us at (217) 241-2287. Your pet's health and happiness are of utmost importance to us, and we are here to support you every step of the way.